|
|
| | Cefetamet pivoxil hydrochloride Basic information |
| Product Name: | Cefetamet pivoxil hydrochloride | | Synonyms: | )(methoxyimino)acetyl)amino)-3-methyl-8-oxo-,(2,2-dimethyl-1-oxopropoxy)methy;7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-methyl-8-oxo-,(2,2-dimethyl-1-oxopropoxy)met5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicaci;monohydrochloride,(6r-(6-alpha,7-beta(z)))-leste;ro15-8075;CEFETAMET PIVOXIL HCL;CEFETAMET PIVOXIL HYDROCHLORIDE;(+)-(6r,7r)-pivaloyloxymethyl 7-[(2-amino-4-thiazolyl);Ceftamet pivoxil hydrochloride | | CAS: | 111696-23-2 | | MF: | C20H26ClN5O7S2 | | MW: | 548.03 | | EINECS: | | | Product Categories: | | | Mol File: | 111696-23-2.mol |  |
| | Cefetamet pivoxil hydrochloride Chemical Properties |
| storage temp. | under inert gas (nitrogen or Argon) at 2-8°C | | solubility | DMSO : ≥ 100 mg/mL (182.47 mM);Water : < 0.1 mg/mL (insoluble) | | CAS DataBase Reference | 111696-23-2(CAS DataBase Reference) |
| | Cefetamet pivoxil hydrochloride Usage And Synthesis |
| Description | Cefetamet pivoxil hydrochloride, an ester prodrug of cefetamet, is an orally active
cephalosporin introduced for the treatment of community-acquired respiratory and
urinary tract infections. Roche indicated that this drug will possibly be the first
third-generation cephalosporin to be launched in some counrries. It is reportedly useful in penicillin-resistant pneumococci, gonococci and H. influenzae infections, but
ineffective against Staphylococci, P. aeruginosa and some non-fermenters. | | Originator | Takeda (Japan) | | Definition | ChEBI: Cefetamet pivoxil hydrochloride is an organic molecular entity. | | Brand name | Globocef |
| | Cefetamet pivoxil hydrochloride Preparation Products And Raw materials |
|